nach oben

Arthritis Research & Therapy

Erschienen in:

01.12.2006 | Review

Arthritis and Pain. Neurogenic origin of joint pain

verfasst von: Jason J McDougall

Erschienen in: Arthritis Research & Therapy | Ausgabe 6/2006

Einloggen, um Zugang zu erhalten

Abstract

Arthritis pain affects millions of people worldwide yet we still have only a limited understanding of what makes our joints ache. This review examines the sensory innervation of diarthroidal joints and discusses the neurophysiological processes that lead to the generation of painful sensation. During inflammation, joint nerves become sensitized to mechanical stimuli through the actions of neuropeptides, eicosanoids, proteinase-activated receptors and ion channel ligands. The contribution of immunocytes to arthritis pain is also reviewed. Finally, the existence of an endogenous analgesic system in joints is considered and the reasons for its inability to control pain are postulated.

Nur mit Berechtigung zugänglich

The burden of musculoskeletal conditions at the start of the new millennium. World Health Organ Tech Rep Ser. 2003, 919: i-x1-218.

Samuel EP: The autonomic and somatic innervation of the articular capsule. Anat Rec. 1952, 113: 53-70. 10.1002/ar.1091130104.PubMed

Skoglund S: Anatomical and physiological studies of knee joint innervation in the cat. Acta Physiol Scand. 1956, 1-101. 36

Sherrington C: The Integrative Action of the Nervous System. 1906, New York: Scribner

Langford LA: Unmyelinated axon ratios in cat motor, cutaneous and articular nerves. Neurosci Lett. 1983, 40: 19-22. 10.1016/0304-3940(83)90085-X.PubMed

Langford LA, Schmidt RF: Afferent and efferent axons in the medial and posterior articular nerves of the cat. Anat Rec. 1983, 206: 71-78. 10.1002/ar.1092060109.PubMed

Hildebrand C, Oqvist G, Brax L, Tuisku F: Anatomy of the rat knee joint and composition of a major articular nerve. Anat Rec. 1991, 229: 545-555. 10.1002/ar.1092290415.PubMed

Marinozzi G, Ferrante F, Gaudio E, Ricci A, Amenta F: Intrinsic innervation of the rat knee joint articular capsule and ligaments. Acta Anat. 1991, 141: 8-14.PubMed

Freeman MAR, Wyke B: The innervation of the knee joint. An anatomical and histological study in the cat. J Anat. 1967, 101: 505-532.PubMedCentralPubMed

10.

O'Connor BL: The mechanoreceptor innervation of the posterior attachments of the lateral meniscus of the dog knee joint. J Anat. 1984, 138: 15-26.PubMedCentralPubMed

11.

Serre CM, Farlay D, Delmas PD, Chenu C: Evidence for a dense and intimate innervation of the bone tissue, including glutamate-containing fibers. Bone. 1999, 25: 623-629. 10.1016/S8756-3282(99)00215-X.PubMed

12.

Mach DB, Rogers SD, Sabino MC, Luger NM, Schwei MJ, Pomonis JD, Keyser CP, Clohisy DR, Adams DJ, O'Leary P, Mantyh PW: Origins of skeletal pain: sensory and sympathetic innervation of the mouse femur. Neuroscience. 2002, 113: 155-166. 10.1016/S0306-4522(02)00165-3.PubMed

13.

McDougall JJ, Bray RC, Sharkey KA: A morphological and immunohistochemical examination of nerves in normal and injured collateral ligaments of rat, rabbit and human knee joints. Anat Rec. 1997, 248: 29-39. 10.1002/(SICI)1097-0185(199705)248:1<29::AID-AR4>3.0.CO;2-A.PubMed

14.

Heppelmann B, Messlinger K, Neiss WF, Schmidt RF: Ultrastructural three-dimensional reconstruction of group III and group IV sensory nerve endings ('free nerve endings') in the knee joint capsule of the cat: evidence for multiple receptive sites. J Comp Neurol. 1990, 292: 103-116. 10.1002/cne.902920107.PubMed

15.

Heppelmann B, McDougall JJ: Inhibitory effect of amiloride and gadolinium on fine afferent nerves in the rat knee: evidence of mechanogated ion channels in joints. Exp Brain Res. 2005, 167: 114-118. 10.1007/s00221-005-0040-z.PubMed

16.

Schaible HG, Schmidt RF: Activation of groups III and IV sensory units in medial articular nerve by local mechanical stimulation of knee joint. J Neurophysiol. 1983, 49: 35-44.PubMed

17.

Schaible HG, Schmidt RF: Responses of fine medial articular nerve afferents to passive movements of knee joints. J Neurophysiol. 1983, 49: 1118-1126.PubMed

18.

Grigg P, Schaible HG, Schmidt RF: Mechanical sensitivity of group III and IV afferents from posterior articular nerve in normal and inflamed cat knee. J Neurophysiol. 1986, 55: 635-643.PubMed

19.

Schaible HG, Schmidt RF: Time course of mechanosensitivity changes in articular afferents during a developing experimental arthritis. J Neurophysiol. 1988, 60: 2180-2195.PubMed

20.

Schaible HG, Schmidt RF: Effects of an experimental arthritis on the sensory properties of fine articular afferent units. J Neurophysiol. 1985, 54: 1109-1122.PubMed

21.

Coggeshall RE, Hong KA, Langford LA, Schaible HG, Schmidt RF: Discharge characteristics of fine medial articular afferents at rest and during passive movements of inflamed knee joints. Brain Res. 1983, 272: 185-188. 10.1016/0006-8993(83)90379-7.PubMed

22.

Schaible H, Schmidt RF, Willis WD: Responses of spinal cord neurones to stimulation of articular afferent fibres in the cat. J Physiol. 1986, 372: 575-593.PubMedCentralPubMed

23.

Guilbaud G, Iggo A, Tegner R: Sensory receptors in ankle joint capsules of normal and arthritic rats. Exp Brain Res. 1985, 58: 29-40. 10.1007/BF00238950.PubMed

24.

Li Z, Proud D, Zhang C, Wiehler S, McDougall JJ: Chronic arthritis downregulates peripheral mu-opioid receptor expression with concomitant loss of endomorphin-1 anti-nociception. Arthritis Rheum. 2005, 52: 3210-3219. 10.1002/art.21359.PubMed

25.

Schuelert N, McDougall JJ: Electrophysiological evidence that the vasoactive intestinal peptide receptor antagonist VIP(6–28) reduces nociception in an animal model of osteoarthritis. Osteoarthritis Cartilage. 2006, 14: 1155-1162. 10.1016/j.joca.2006.04.016.PubMed

26.

Reeves B: Negative pressures in knee joints. Nature. 1966, 212: 1046-10.1038/2121046a0.

27.

Levick JR: An investigation into the validity of subatmospheric pressure recordings from synovial fluid and their dependence on joint angle. J Physiol. 1979, 289: 55-67.PubMedCentralPubMed

28.

Jayson MI, St Dixon AJ: Intra-articular pressure in rheumatoid arthritis of the knee. I. Pressure changes during passive joint distension. Ann Rheum Dis. 1970, 29: 261-265.PubMedCentralPubMed

29.

Andrew BL, Dodt E: The deployment of sensory nerve endings at the knee joint of the cat. Acta Physiol Scand. 1953, 28: 8287-8296.PubMed

30.

Ferrell WR, Nade S, Newbold PJ: The interrelation of neural discharge, intra-articular pressure, and joint angle in the knee of the dog. J Physiol. 1986, 373: 353-365.PubMedCentralPubMed

31.

Butler DL, Noyes FR, Grood ES: Ligamentous restraints to anterior-posterior drawer in the human knee: a biomechanical study. J Bone Joint Surg Am. 1980, 62A: 259-270.

32.

Gollehon DL, Torzilli PA, Warren RF: The role of the posterolateral and cruciate ligaments in the stability of the human knee. J Bone Joint Surg Am. 1987, 69-A: 233-242.

33.

Markolf KL, Kochan A, Amstutz HC: Measurement of knee stiffness and laxity in patients with documented absence of the anterior cruciate ligament. J Bone Joint Surg Am. 1984, 66-A: 242-253.

34.

McDougall JJ, Bray RC: Animal models of ligament repair. Animal Models in Orthopaedic Research. Edited by: An YH, Friedman RD. 1999, Boca Raton, Florida: CRC Press LLC, 461-476.

35.

Marshall JL, Olsson S-E: Instability of the knee: a long term experimental study in dogs. J Bone Joint Surg Am. 1971, 53A: 1561-1570.

36.

Pond MJ, Nuki G: Experimentally-induced osteoarthritis in dog. Ann Rheum Dis. 1973, 32: 387-388.PubMedCentralPubMed

37.

Jacobsen K: Osteoarthrosis following insufficiency of the cruciate ligaments in man: a clinical study. Acta Orthop Scand. 1977, 48: 520-526.PubMed

38.

McDaniel WJ, Dameron TB: Untreated ruptures of the anterior cruciate ligament. J Bone Joint Surg Am. 1980, 62-A: 696-705.

39.

Brandt KD, Braunstein EM, Visco DM, O'Connor B, Heck D, Albrecht M: Anterior (cranial) cruciate ligament transection in the dog: a bona fide model of osteoarthritis, not merely of cartilage injury and repair. J Rheumatol. 1991, 18: 436-446.PubMed

40.

Brandt KD, Myers SL, Burr D, Albrecht M: Osteoarthritic changes in canine articular cartilage, subchondral bone, and synovium fifty-four weeks after transection of the anterior cruciate ligament. Arthritis Rheum. 1991, 34: 1560-1570.PubMed

41.

Gomez-Barrena E, Nunez A, Martinez-Moreno E, Valls J, Munuera L: Neural and muscular electric activity in the cat's knee. Changes when the anterior cruciate ligament is transected. Acta Orthop Scand. 1997, 68: 149-155.PubMed

42.

Ahmed M, Bjurholm A, Kreicbergs A, Schultzberg M: Neuropeptide Y, tyrosine hydroxylase, and vasoactive intestinal polypeptide-immunoreactive nerve fibres in the vertebral bodies, discs, dura mater, and spinal ligaments of the rat lumbar spine. Spine. 1993, 18: 268-273.PubMed

43.

Ahmed M, Bjurholm A, Schultzberg M, Theodorsson E, Kreicbergs A: Increased levels of substance P and calcitonin gene-related peptide in rat adjuvant arthritis. A combined immunohistochemical and radioimmunoassay analysis. Arthritis Rheum. 1995, 38: 699-709.PubMed

44.

Buma P, Elmans L, Van Den Berg WB, Schrama LH: Neurovascular plasticity in the knee joint of an arthritic mouse model. Anat Rec. 2000, 260: 51-61. 10.1002/1097-0185(20000901)260:1<51::AID-AR60>3.0.CO;2-9.PubMed

45.

Hanesch U, Heppelmann B, Schmidt RF: Substance P and calcitonin gene-related peptide immunoreactivity in primary afferent neurons of the cat's knee joint. Neuroscience. 1991, 45: 185-193. 10.1016/0306-4522(91)90114-4.PubMed

46.

Heppelmann B, Shahbazian Z, Hanesch U: Quantitative examination of calcitonin gene-related peptide immunoreactive nerve fibres in the cat knee joint. Anat Embryol (Berl). 1997, 195: 525-530. 10.1007/s004290050072.

47.

Heppelmann B, Pawlak M: Sensitisation of articular afferents in normal and inflamed knee joints by substance P in the rat. Neurosci Lett. 1997, 223: 97-100. 10.1016/S0304-3940(97)13408-5.PubMed

48.

Neugebauer V, Rumenapp P, Schaible HG: Calcitonin gene-related peptide is involved in the spinal processing of mechanosensory input from the rat's knee joint and in the generation and maintenance of hyperexcitability of dorsal horn-neurons during development of acute inflammation. Neuroscience. 1996, 71: 1095-1109. 10.1016/0306-4522(95)00473-4.PubMed

49.

Ahmed M, Bjurholm A, Theodorsson E, Schultzberg M, Kreicbergs A: Neuropeptide Y- and vasoactive intestinal polypeptide-like immunoreactivity in adjuvant arthritis: effects of capsaicin treatment. Neuropeptides. 1995, 29: 33-43. 10.1016/0143-4179(95)90054-3.PubMed

50.

Abramovici A, Daizade I, Yosipovitch Z, Gibson SJ, Polak JM: The distribution of peptide-containing nerves in the synovia of the cat knee joint. Histol Histopathol. 1991, 6: 469-476.PubMed

51.

Catre MG, Salo PT: Quantitative analysis of the sympathetic innervation of the rat knee joint. J Anat. 1999, 194: 233-239. 10.1046/j.1469-7580.1999.19420233.x.PubMedCentralPubMed

52.

McDougall JJ, Watkins L, Li Z: Vasoactive intestinal peptide (VIP) is a modulator of joint pain in a rat model of osteoarthritis. Pain. 2006, 123: 98-105. 10.1016/j.pain.2006.02.015.PubMed

53.

Neal CR, Mansour A, Reinscheid R, Nothacker HP, Civelli O, Watson SJ: Localization of orphanin FQ (nociceptin) peptide and messenger RNA in the central nervous system of the rat. J Comp Neurol. 1999, 406: 503-547. 10.1002/(SICI)1096-9861(19990419)406:4<503::AID-CNE7>3.0.CO;2-P.PubMed

54.

Riedl M, Shuster S, Vulchanova L, Wang J, Loh HH, Elde R: Orphanin FQ/nociceptin-immunoreactive nerve fibers parallel those containing endogenous opioids in rat spinal cord. Neuroreport. 1996, 7: 1369-1372.PubMed

55.

Schuligoi R, Amann R, Angelberger P, Peskar BA: Determination of nociceptin-like immunoreactivity in the rat dorsal spinal cord. Neurosci Lett. 1997, 224: 136-138. 10.1016/S0304-3940(97)13453-X.PubMed

56.

Civelli O, Nothacker HP, Reinscheid R: Reverse physiology: discovery of the novel neuropeptide, orphanin FQ/nociceptin. Crit Rev Neurobiol. 1998, 12: 163-176.PubMed

57.

Darland T, Grandy DK: The orphanin FQ system: an emerging target for the management of pain?. Brit J Anaesth. 1998, 81: 29-37.PubMed

58.

Darland T, Heinricher MM, Grandy DK: Orphanin FQ/nociceptin: a role in pain and analgesia, but so much more. Trends Neurosci. 1998, 21: 215-221. 10.1016/S0166-2236(97)01204-6.PubMed

59.

McDougall JJ, Pawlak M, Hanesch U, Schmidt RF: Peripheral modulation of rat knee joint afferent mechanosensitivity by nociceptin/orphanin FQ. Neurosci Lett. 2000, 288: 123-126. 10.1016/S0304-3940(00)01211-8.PubMed

60.

McDougall JJ, Hanesch U, Pawlak M, Schmidt RF: Participation of NK₁ receptors in nociceptin-induced modulation of rat knee joint mechanosensitivity. Exp Brain Res. 2001, 137: 249-253. 10.1007/s002210000650.PubMed

61.

McDougall JJ, Larson SEM: Nociceptin/orphanin FQ evokes knee joint pain in rats via a mast cell independent mechanism. Neurosci Lett. 2006, 398: 135-138. 10.1016/j.neulet.2005.12.066.PubMed

62.

Kean WF, Buchanan WW: The use of NSAIDs in rheumatic disorders 2005: a global perspective. Inflammopharmacology. 2005, 13: 343-370. 10.1163/156856005774415565.PubMed

63.

Schaible H, Grubb BD: Afferent and spinal mechanisms of joint pain. Pain. 1993, 55: 5-54. 10.1016/0304-3959(93)90183-P.PubMed

64.

McQueen DS: Inflammatory pain and the joint. Pain and Neurogenic Inflammation. Edited by: Brain SD, Moore PK. 1999, Basel, Switzerland: Birkhäuser Verlag, 137-166.

65.

Smith WL, Garavito RM, DeWitt DL: Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2. J Biol Chem. 1996, 271: 33157-33160. 10.1074/jbc.271.52.33157.PubMed

66.

Vane JR, Botting RM: Mechanism of action of anti-inflammatory drugs. Scand J Rheumatol Suppl. 1996, 9-21. 102

67.

Crofford LJ, Wilder RL, Ristimaki AP, Sano H, Remmers EF, Epps HR, Hla T: Cyclooxygenase-1 and -2 expression in rheumatoid synovial tissues. Effects of interleukin-1 beta, phorbol ester, and corticosteroids. J Clin Invest. 1994, 93: 1095-1101.PubMedCentralPubMed

68.

Siegle I, Klein T, Backman JT, Saal JG, Nusing RM, Fritz P: Expression of cyclooxygenase 1 and cyclooxygenase 2 in human synovial tissue: differential elevation of cyclooxygenase 2 in inflammatory joint diseases. Arthritis Rheum. 1998, 41: 122-129. 10.1002/1529-0131(199801)41:1<122::AID-ART15>3.0.CO;2-8.PubMed

69.

Bombardier C, Laine L, Reicin A, Shapiro D, Burgos-Vargas R, Davis B, Day R, Ferraz MB, Hawkey CJ, Hochberg MC, et al: Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group. New Engl J Med. 2000, 343: 1520-1528. 10.1056/NEJM200011233432103. 2 p following 1528PubMed

70.

Schaible HG, Schmidt RF: Excitation and sensitization of fine articular afferents from cat's knee joint by prostaglandin E2. J Physiol. 1988, 403: 91-104.PubMedCentralPubMed

71.

Schepelmann K, Messlinger K, Schaible HG, Schmidt RF: Inflammatory mediators and nociception in the joint: excitation and sensitization of slowly conducting afferent fibers of cat's knee by prostaglandin I2. Neuroscience. 1992, 50: 237-247. 10.1016/0306-4522(92)90395-I.PubMed

72.

Birrell GJ, McQueen DS, Iggo A, Coleman RA, Grubb BD: PGI2-induced activation and sensitization of articular mechanonociceptors. Neurosci Lett. 1991, 124: 5-8. 10.1016/0304-3940(91)90809-8.PubMed

73.

Grubb BD, Birrell GJ, McQueen DS, Iggo A: The role of PGE2 in the sensitization of mechanoreceptors in normal and inflamed ankle joints of the rat. Exp Brain Res. 1991, 84: 383-392. 10.1007/BF00231460.PubMed

74.

Heppelmann B, Pfeffer A, Schaible HG, Schmidt RF: Effects of acetylsalicylic acid and indomethacin on single groups III and IV sensory units from acutely inflamed joints. Pain. 1986, 26: 337-351. 10.1016/0304-3959(86)90062-X.PubMed

75.

Guilbaud G, Iggo A: The effect of lysine acetylsalicylate on joint capsule mechanoreceptors in rats with polyarthritis. Exp Brain Res. 1985, 61: 164-168. 10.1007/BF00235631.PubMed

76.

Laird JM, Herrero JF, Garcia de la Rubia P, Cervero F: Analgesic activity of the novel COX-2 preferring NSAID, meloxicam in mono-arthritic rats: central and peripheral components. Inflamm Res. 1997, 46: 203-210. 10.1007/s000110050174.PubMed

77.

Deutsch DG, Chin SA: Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist. Biochem Pharmacol. 1993, 46: 791-796. 10.1016/0006-2952(93)90486-G.PubMed

78.

Pertwee RG: Cannabinoid receptors and pain. Prog Neurobiol. 2001, 63: 569-611. 10.1016/S0301-0082(00)00031-9.PubMed

79.

Griffin G, Fernando SR, Ross RA, McKay NG, Ashford ML, Shire D, Huffman JW, Yu S, Lainton JA, Pertwee RG: Evidence for the presence of CB2-like cannabinoid receptors on peripheral nerve terminals. Eur J Pharmacol. 1997, 339: 53-61. 10.1016/S0014-2999(97)01336-8.PubMed

80.

Matsuda LA, Lolait SJ, Brownstein MJ, Young AC, Bonner TI: Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature. 1990, 346: 561-564. 10.1038/346561a0.PubMed

81.

Munro S, Thomas KL, Abu-Shaar M: Molecular characterization of a peripheral receptor for cannabinoids. Nature. 1993, 365: 61-65. 10.1038/365061a0.PubMed

82.

Tsou K, Brown S, Sanudo-Pena MC, Mackie K, Walker JM: Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system. Neuroscience. 1998, 83: 393-411. 10.1016/S0306-4522(97)00436-3.PubMed

83.

Rice AS, Farquhar-Smith WP, Nagy I: Endocannabinoids and pain: spinal and peripheral analgesia in inflammation and neuropathy. Prostaglandins Leukot Essent Fatty Acids. 2002, 66: 243-256. 10.1054/plef.2001.0362.PubMed

84.

Quartilho A, Mata HP, Ibrahim MM, Vanderah TW, Porreca F, Makriyannis A, Malan TP: Inhibition of inflammatory hyperalgesia by activation of peripheral CB2 cannabinoid receptors. Anesthesiology. 2003, 99: 955-960. 10.1097/00000542-200310000-00031.PubMed

85.

Farquhar-Smith WP, Egertova M, Bradbury EJ, McMahon SB, Rice AS, Elphick MR: Cannabinoid CB(1) receptor expression in rat spinal cord. Mol Cell Neurosci. 2000, 15: 510-521. 10.1006/mcne.2000.0844.PubMed

86.

Gauldie SD, McQueen DS, Pertwee R, Chessell IP: Anandamide activates peripheral nociceptors in normal and arthritic rat knee joints. Br J Pharmacol. 2001, 132: 617-621. 10.1038/sj.bjp.0703890.PubMedCentralPubMed

87.

Baker CL, McDougall JJ: The cannabinomimetic arachidonyl-2-chloroethylamide (ACEA) acts on capsaicin-sensitive TRPV1 receptors but not cannabinoid receptors in rat joints. Br J Pharmacol. 2004, 142: 1361-1367. 10.1038/sj.bjp.0705902.PubMedCentralPubMed

88.

Zygmunt PM, Petersson J, Andersson DA, Chuang H, Sorgard M, Di Marzo V, Julius D, Hogestatt ED: Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature. 1999, 400: 452-457. 10.1038/22761.PubMed

89.

Akopian AN, Souslova V, England S, Okuse K, Ogata N, Ure J, Smith A, Kerr BJ, McMahon SB, Boyce S, et al: The tetrodotoxin-resistant sodium channel SNS has a specialized function in pain pathways. Nat Neurosci. 1999, 2: 541-548. 10.1038/9195.PubMed

90.

Djouhri L, Fang X, Okuse K, Wood JN, Berry CM, Lawson SN: The TTX-resistant sodium channel Nav1.8 (SNS/PN3): expression and correlation with membrane properties in rat nociceptive primary afferent neurons. J Physiol. 2003, 550: 739-752. 10.1113/jphysiol.2003.042127.PubMedCentralPubMed

91.

Black JA, Liu S, Tanaka M, Cummins TR, Waxman SG: Changes in the expression of tetrodotoxin-sensitive sodium channels within dorsal root ganglia neurons in inflammatory pain. Pain. 2004, 108: 237-247. 10.1016/j.pain.2003.12.035.PubMed

92.

Gould HJ, England JD, Liu ZP, Levinson SR: Rapid sodium channel augmentation in response to inflammation induced by complete Freund's adjuvant. Brain Res. 1998, 802: 69-74. 10.1016/S0006-8993(98)00568-X.PubMed

93.

Flake NM, Gold MS: Inflammation alters sodium currents and excitability of temporomandibular joint afferents. Neurosci Lett. 2005, 384: 294-299. 10.1016/j.neulet.2005.04.091.PubMed

94.

England S, Bevan S, Docherty RJ: PGE2 modulates the tetrodotoxin-resistant sodium current in neonatal rat dorsal root ganglion neurones via the cyclic AMP-protein kinase A cascade. J Physiol. 1996, 495: 429-440.PubMedCentralPubMed

95.

Gold MS, Reichling DB, Shuster MJ, Levine JD: Hyperalgesic agents increase a tetrodotoxin-resistant Na+ current in nociceptors. Proc Natl Acad Sci USA. 1996, 93: 1108-1112. 10.1073/pnas.93.3.1108.PubMedCentralPubMed

96.

Laird JM, Carter AJ, Grauert M, Cervero F: Analgesic activity of a novel use-dependent sodium channel blocker, crobenetine, in mono-arthritic rats. Br J Pharmacol. 2001, 134: 1742-1748. 10.1038/sj.bjp.0704428.PubMedCentralPubMed

97.

Yaksh TL: Calcium channels as therapeutic targets in neuropathic pain. J Pain. 2006, 7: S13-S30. 10.1016/j.jpain.2005.09.007.PubMed

98.

Hanesch U, McDougall JJ, Pawlak M: Inhibitory effects of gabapentin on rat articular afferent mechanosensitivity. Reg Pep. 2000, 89: 63-

99.

Peier AM, Moqrich A, Hergarden AC, Reeve AJ, Andersson DA, Story GM, Earley TJ, Dragoni I, McIntyre P, Bevan S, Patapoutian A: A TRP channel that senses cold stimuli and menthol. Cell. 2002, 108: 705-715. 10.1016/S0092-8674(02)00652-9.PubMed

100.

McKemy DD, Neuhausser WM, Julius D: Identification of a cold receptor reveals a general role for TRP channels in thermosensation. Nature. 2002, 416: 52-58. 10.1038/nature719.PubMed

101.

Caterina MJ, Schumacher MA, Tominaga M, Rosen TA, Levine JD, Julius D: The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature. 1997, 389: 816-824. 10.1038/39807.PubMed

102.

Varga A, Nemeth J, Szabo A, McDougall JJ, Zhang C, Elekes K, Pinter E, Szolcsanyi J, Helyes Z: Effects of the novel TRPV1 receptor antagonist SB366791 in vitro and in vivo in the rat. Neurosci Lett. 2005, 385: 137-142. 10.1016/j.neulet.2005.05.015.PubMed

103.

Neugebauer V, Schaible HG, Schmidt RF: Sensitization of articular afferents to mechanical stimuli by bradykinin. Pflügers Arch. 1989, 415: 330-335. 10.1007/BF00370884.PubMed

104.

Kanaka R, Schaible HG, Schmidt RF: Activation of fine articular afferent units by bradykinin. Brain Res. 1985, 327: 81-90. 10.1016/0006-8993(85)91501-X.PubMed

105.

Herbert MK, Just H, Schmidt RF: Histamine excites groups III and IV afferents from the cat knee joint depending on their resting activity. Neurosci Lett. 2001, 305: 95-98. 10.1016/S0304-3940(01)01817-1.PubMed

106.

Birrell GJ, McQueen DS, Iggo A, Grubb BD: The effects of 5-HT on articular sensory receptors in normal and arthritic rats. Br J Pharmacol. 1990, 101: 715-721.PubMedCentralPubMed

107.

Dowd E, McQueen DS, Chessell IP, Humphrey PP: P2X receptor-mediated excitation of nociceptive afferents in the normal and arthritic rat knee joint. Br J Pharmacol. 1998, 125: 341-346. 10.1038/sj.bjp.0702080.PubMedCentralPubMed

108.

Dowd E, McQueen DS, Chessell IP, Humphrey PP: Adenosine A1 receptor-mediated excitation of nociceptive afferents innervating the normal and arthritic rat knee joint. Br J Pharmacol. 1998, 125: 1267-1271. 10.1038/sj.bjp.0702185.PubMedCentralPubMed

109.

Kelly DC, Asghar AU, Marr CG, McQueen DS: Nitric oxide modulates articular sensory discharge and responsiveness to bradykinin in normal and arthritic rats in vivo. NeuroReport. 2001, 12: 121-125. 10.1097/00001756-200101220-00032.PubMed

110.

Heppelmann B, Messlinger K, Neiss WF, Schmidt RF: Fine sensory innervation of the knee joint capsule by group III and group IV nerve fibers in the cat. J Comp Neurol. 1995, 351: 415-428. 10.1002/cne.903510308.PubMed

111.

Hukkanen M, Grönblad M, Rees R, Konttinen YT, Gibson SJ, Hietanen J, Polak JM, Brewerton DA: Regional distribution of mast cells and peptide containing nerves in normal and adjuvant arthritic rat synovium. J Rheumatol. 1991, 18: 177-183.PubMed

112.

Bjerknes L, Coderre TJ, Green PG, Basbaum AI, Levine JD: Neutrophils contribute to sympathetic nerve terminal-dependent plasma extravasation in the knee joint of the rat. Neuroscience. 1991, 43: 679-685. 10.1016/0306-4522(91)90326-J.PubMed

113.

Lo EJ, Green PG, Miao FJ, Relchling DB, Levine JD: Bradykinin-induced neurogenic migration of neutrophils into the rat knee joint. NeuroReport. 1999, 10: 3821-3824.PubMed

114.

Skofitsch G, Donnerer J, Petronijevic S, Saria A, Lembeck F: Release of histamine by neuropeptides from the perfused rat hindquarter. Naunyn Schmiedeberg's Arch Pharmacol. 1983, 322: 153-157. 10.1007/BF00512389.

115.

Shanahan F, Denburg JA, Fox J, Bienenstock J, Befus D: Mast cell heterogeneity: effects of neuroenteric peptides on histamine release. J Immunol. 1985, 135: 1331-1337.PubMed

116.

Piotrowski W, Foreman JC: On the actions of substance P, somatostatin, and vasoactive intestinal polypeptide on rat peritoneal mast cells and in human skin. Naunyn Schmiedeberg's Arch Pharmacol. 1985, 331: 364-368. 10.1007/BF00500821.

117.

Nemeth J, Helyes Z, Oroszi G, Than M, Pinter E, Szolcsanyi J: Inhibition of nociceptin on sensory neuropeptide release and mast cell-mediated plasma extravasation in rats. Eur J Pharmacol. 1998, 347: 101-104. 10.1016/S0014-2999(98)00216-7.PubMed

118.

Foreman J, Jordan C: Histamine release and vascular changes induced by neuropeptides. Agents Actions. 1983, 13: 105-116. 10.1007/BF01967311.PubMed

119.

Johnson AR, Erdos EG: Release of histamine from mast cells by vasoactive peptides. Proc Soc Exp Biol Med. 1973, 142: 1252-1256.PubMed

120.

Kimura T, Kitaichi K, Hiramatsu K, Yoshida M, Ito Y, Kume H, Yamaki K, Suzuki R, Takagi K: Intradermal application of nociceptin increases vascular permeability in rats: the possible involvement of histamine release from mast cells. Eur J Pharmacol. 2000, 407: 327-332. 10.1016/S0014-2999(00)00746-9.PubMed

121.

Serhan CN, Fierro IM, Chiang N, Pouliot M: Cutting edge: nociceptin stimulates neutrophil chemotaxis and recruitment: inhibition by aspirin-triggered-15-epi-lipoxin A4. J Immunol. 2001, 166: 3650-3654.PubMed

122.

Kidd BL: The expanding role of the nervous system in arthritis. EULAR Bull. 1993, 4: 134-137.

123.

Fiset ME, Gilbert C, Poubelle PE, Pouliot M: Human neutrophils as a source of nociceptin: a novel link between pain and inflammation. Biochemistry. 2003, 42: 10498-10505. 10.1021/bi0300635.PubMedCentralPubMed

124.

Zhang C, McDougall JJ: Stimulation of sensory neuropeptide release by nociceptin/orphanin FQ leads to hyperaemia in acutely inflamed rat knees. Br J Pharmacol. 2006, 148: 938-946. 10.1038/sj.bjp.0706804.PubMedCentralPubMed

125.

Lavery JP, Lisse JR: Preliminary study of the tryptase levels in the synovial fluid of patients with inflammatory arthritis. Ann Allergy. 1994, 72: 425-427.PubMed

126.

Nakano S, Ikata T, Kinoshita I, Kanematsu J, Yasuoka S: Characteristics of the protease activity in synovial fluid from patients with rheumatoid arthritis and osteoarthritis. Clin Exp Rheumatol. 1999, 17: 161-170.PubMed

127.

Mican JM, Metcalf DD: Arthritis and mast cell activation. J Allergy Clin Immunol. 1990, 86: 677-683.PubMed

128.

de Paulis A, Marino I, Ciccarelli A, de Crescenzo G, Concardi M, Verga L, Arbustini E, Marone G: Human synovial mast cells. I. Ultrastructural in situ and in vitro immunologic characterization. Arthritis Rheum. 1996, 39: 1222-1233.PubMed

129.

Vergnolle N, Wallace JL, Bunnett NW, Hollenberg MD: Protease-activated receptors in inflammation, neuronal signalling and pain. Trends Pharmacol Sci. 2001, 22: 146-152. 10.1016/S0165-6147(00)01634-5.PubMed

130.

Vergnolle N, Bunnett NW, Sharkey KA, Brussee V, Compton SJ, Grady EF, Cirino G, Gerard N, Basbaum AI, Andrade-Gordon P, et al: Proteinase-activated receptor-2 and hyperalgesia: a novel pain pathway. Nat Med. 2001, 7: 821-826. 10.1038/89945.PubMed

131.

McDougall JJ, Barin AK, McDougall CM: Loss of vasomotor responsiveness to the m-opioid receptor ligand endomorphin-1 in adjuvant monoarthritic rat knee joints. Am J Physiol: Reg Integr Comp Physiol. 2004, 286: R634-R641.

132.

McDougall JJ, Baker CL, Hermann PM: Attenuation of knee joint inflammation by peripherally administered endomorphin-1. J Mol Neurosci. 2004, 22: 125-137. 10.1385/JMN:22:1-2:125.PubMed

133.

Heppelmann B, Just S, Pawlak M: Galanin influences the mechanosensitivity of sensory endings in the rat knee joint. Eur J Neurosci. 2000, 12: 1567-1572. 10.1046/j.1460-9568.2000.00045.x.PubMed

134.

Heppelmann B, Pawlak M: Inhibitory effect of somatostatin on the mechanosensitivity of articular afferents in normal and inflamed knee joints of the rat. Pain. 1997, 73: 377-382. 10.1016/S0304-3959(97)00124-3.PubMed

135.

Heppelmann B, Pawlak M, Just S, Schmidt RF: Cortical projection of the rat knee joint innervation and its processing in the somatosensory areas SI and SII. Exp Brain Res. 2001, 141: 501-506. 10.1007/s002210100888.PubMed

136.

Huyser BA, Parker JC: Negative affect and pain in arthritis. Rheum Dis Clin North Am. 1999, 25: 105-121, vi. 10.1016/S0889-857X(05)70057-0.PubMed

137.

Neugebauer V, Li W: Differential sensitization of amygdala neurons to afferent inputs in a model of arthritic pain. J Neurophysiol. 2003, 89: 716-727. 10.1152/jn.00799.2002.PubMed

138.

LeDoux JE: Emotion circuits in the brain. Annu Rev Neurosci. 2000, 23: 155-184. 10.1146/annurev.neuro.23.1.155.PubMed

Titel: Arthritis and Pain. Neurogenic origin of joint pain
verfasst von: Jason J McDougall
Publikationsdatum: 01.12.2006
Verlag: BioMed Central
Erschienen in: Arthritis Research & Therapy / Ausgabe 6/2006
Elektronische ISSN: 1478-6362
DOI: https://doi.org/10.1186/ar2069

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 6/2006

HLA-C locus alleles may modulate the clinical expression of psoriatic arthritis

Response to the commentary 'Pooled indices to measure rheumatoid arthritis activity: a good reflection of the physician's mind'

PUMA-mediated apoptosis in fibroblast-like synoviocytes does not require p53

Exogenous glucosamine globally protects chondrocytes from the arthritogenic effects of IL-1β

Transition of healthy to diseased synovial tissue in rheumatoid arthritis is associated with gain of mesenchymal/fibrotic characteristics